Navigation Links
Ophthalmic Women Leaders (OWL) Names Pamela Gleeson, CFO Of Santen Inc., as 2010 President

Ophthalmic Women Leaders (OWL) has appointed Pamela Gleeson, Chief Financial Officer (CFO) of Santen Inc., as its 2010 president.

San Francisco (Vocus) -- Ophthalmic Women Leaders (OWL) has appointed Pamela Gleeson, Chief Financial Officer (CFO) of Santen Inc., as its 2010 president.

Prior to her appointment as president, Gleeson previously served as chair of the organization’s Finance Committee.

“We are pleased to introduce and welcome Pamela as our new president," said Molly Schar, Executive Director of OWL. "With a deep understanding of the ophthalmic field, established relationships in the industry and a strong commitment to mentoring future ophthalmic leaders, Pamela has already moved effortlessly into her role as president with plans for expanding our offerings."

“I am thrilled to be serving as president, and to be a part of an organization and mentoring program about which I’m very passionate," said Gleeson. “Additionally, I am fortunate to work with one of OWL's founding members, Santen CEO Adrienne Graves, who encouraged me to become involved with OWL in its early years. This is an exciting time for the ophthalmic industry, with many new technologies and treatments on the horizon, as well as for women in ophthalmology, where opportunities continue to emerge and grow.”

Pamela Gleeson joined Santen in 1997 and has served as its CFO since 2003. During her career at Santen, Gleeson has held positions in business development, project management, new product development and marketing before heading the finance department and serving on the executive strategy committee. Prior to Santen, Gleeson held finance positions in the high tech, mortgage banking services and retail food industries, after beginning her career at KPMG. Gleeson earned her Bachelor of Science degree in Business Administration (Finance and Accounting) from the University of California at Berkeley and is a California Certified Public Accountant (inactive). She also serves on the boards of the Napa Chamber of Commerce and Leadership Napa Valley.

About Santen Inc.
Santen Inc., based in Napa, California, is the U.S. subsidiary of Santen Pharmaceutical Co., Ltd., a billion-dollar global company headquartered in Osaka, Japan since 1890. Santen researches, develops and markets ophthalmic products for physicians worldwide. Among prescription ophthalmic pharmaceuticals, Santen holds the top share within the Japanese and Chinese markets and is one of the leading ophthalmic companies worldwide. Santen has subsidiaries in the U.S., Europe and Asia, including its wholly-owned Napa, California-based Santen Inc. For more information, visit

About OWL
Founded in 2003, Ophthalmic Women Leaders (OWL) is a professional membership association whose mission is to offer professional development, provide networking opportunities and promote personal growth for women in ophthalmology. For more information, visit

# # #

Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Ophthalmic Equipment Distributor, Latham & Phillips SE Division, Unveils Website
2. ARVO Foundation and Pfizer Ophthalmics honor Carl B. Camras with translational research award
3. Sirion Therapeutics Announces FDA Approval of Zirgan(TM) (Ganciclovir Ophthalmic Gel) 0.15% for Herpetic Keratitis
4. Ophthalmic Consultants of Long Island (OCLI), the Largest and One of the Most Prestigious Multi-Specialty Ophthalmology Practices on Long Island, Participates in Mission Cataract USA
5. Dermatologic and Ophthalmic Drugs Advisory Committee Unanimously Recommends Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
6. Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis (Pink Eye)
7. Endure Medical Redefines Ophthalmic Surgical Microscopes
8. VIDEO from Medialink and Pfizer Ophthalmics: On World Glaucoma Day, Keep an Eye on the Future
9. ConvaTec Announces Divestiture of Unomedical Wound Care and Ophthalmics Business
10. AUDIO from Medialink and Pfizer Ophthalmics: Glaucoma - The Sneak Thief of Sight
11. STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses
Post Your Comments:
Related Image:
Ophthalmic Women Leaders (OWL) Names Pamela Gleeson, CFO Of Santen Inc., as 2010 President
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: